OTC Pharmaceuticals - Puerto Rico

  • Puerto Rico
  • The OTC Pharmaceuticals market in Puerto Rico is projected to generate a revenue of US$621.40m in 2024.
  • It is expected to experience an annual growth rate of 3.60% (CAGR 2024-2029).
  • Among the various markets, Other OTC Pharmaceuticals dominates with a market volume of US$210.50m in 2024.
  • Comparatively, the in the United States leads in revenue generation, reaching US$41,240.00m in the same year.
  • When considering the population figures, the per person revenue in Puerto Rico is estimated to be US$190.10 in 2024.
  • Looking ahead, online sales are projected to contribute 9.35% of the total revenue in the OTC Pharmaceuticals market by 2024.
  • The OTC Pharmaceuticals market in Puerto Rico is experiencing a surge in demand for natural remedies and herbal supplements.

Key regions: United States, China, Germany, Japan, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Puerto Rico is experiencing steady growth due to various factors.

Customer preferences:
Customers in Puerto Rico have a strong preference for over-the-counter (OTC) pharmaceutical products. This is mainly driven by the convenience and accessibility of these products. OTC medications are readily available in local pharmacies and supermarkets, allowing customers to easily purchase them without the need for a prescription. Additionally, customers appreciate the affordability of OTC medications compared to prescription drugs, making them a popular choice for managing common ailments and minor health issues.

Trends in the market:
One of the key trends in the OTC Pharmaceuticals market in Puerto Rico is the increasing demand for preventive healthcare products. Customers are becoming more proactive in managing their health and are seeking OTC medications and supplements that can help prevent illnesses and promote overall well-being. This trend is driven by a growing awareness of the importance of preventive healthcare and the desire to lead a healthier lifestyle.Another significant trend is the rising popularity of natural and herbal remedies. Customers in Puerto Rico are increasingly turning to natural alternatives for managing their health conditions. This trend is influenced by a preference for organic and holistic approaches to healthcare. As a result, there is a growing market for OTC herbal supplements and homeopathic remedies.

Local special circumstances:
Puerto Rico's unique status as a territory of the United States has an impact on the OTC Pharmaceuticals market. The island's healthcare system is heavily influenced by the regulations and standards of the U.S. Food and Drug Administration (FDA). This ensures that OTC medications available in Puerto Rico meet the same safety and efficacy standards as those in the mainland U.S. This provides customers with a sense of confidence and trust in the OTC products available in the market.

Underlying macroeconomic factors:
The economic stability of Puerto Rico plays a significant role in the growth of the OTC Pharmaceuticals market. As the economy improves, customers have more disposable income to spend on healthcare products. This allows them to invest in OTC medications and supplements to manage their health effectively. Additionally, the tourism industry in Puerto Rico contributes to the growth of the OTC Pharmaceuticals market. Tourists visiting the island often purchase OTC medications for minor health issues, boosting the demand for these products.In conclusion, the OTC Pharmaceuticals market in Puerto Rico is thriving due to customer preferences for convenience and affordability. The increasing demand for preventive healthcare products and natural remedies further drives the market's growth. Puerto Rico's unique status as a U.S. territory and its improving economy also contribute to the expansion of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)